Open Access
Asian Pacific Journal of Cancer Prevention
Asian Pacific Organization for Cancer Prevention
ISSN:
15137368, 2476762X
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q3
SJR
0.446
CiteScore
2.8
Categories
Epidemiology
Oncology
Public Health, Environmental and Occupational Health
Cancer Research
Areas
Biochemistry, Genetics and Molecular Biology
Medicine
Years of issue
2000-2023
journal names
Asian Pacific Journal of Cancer Prevention
Top-3 citing journals
Asian Pacific Journal of Cancer Prevention
(11059 citations)

PLoS ONE
(1572 citations)

International Journal of Molecular Sciences
(1489 citations)
Most cited in 5 years
Found
Publications found: 119

Insights into Microsporidia Evolution from Early Diverging Microsporidia
Corsaro D.
Microsporidia have drastically modified genomes and cytology resulting from their high level of adaptation to intracytoplasmic parasitism. Their origins, which had long remained enigmatic, were placed within the line of Rozella, a primitive endoparasitic chytrid. These origins became more and more refined with the discovery of various parasites morphologically similar to the primitive lines of microsporidia (Metchnikovellids and Chytridiopsids) but which possess fungal-like genomes and functional mitochondria. These various parasites turn out to be distinct missing links between a large assemblage of chytrid-like rozellids and the true microsporidians, which are actually a very evolved branch of the rozellids themselves. The question of how to consider the historically known Microsporidia and the various microsporidia-like organisms within paraphyletic rozellids is discussed.

Factors That Determine Microsporidia Infection and Host Specificity
Willis A.R., Reinke A.W.
Microsporidia are a large phylum of obligate intracellular parasites that infect an extremely diverse range of animals and protists. In this chapter, we review what is currently known about microsporidia host specificity and what factors influence microsporidia infection. Extensive sampling in nature from related hosts has provided insight into the host range of many microsporidia species. These field studies have been supported by experiments conducted in controlled laboratory environments which have helped to demonstrate host specificity. Together, these approaches have revealed that, while examples of generalist species exist, microsporidia specificity is often narrow, and species typically infect one or several closely related hosts. For microsporidia to successfully infect and complete their life cycle within a compatible host, several steps must occur, including spore germination, host cell invasion, and proliferation of the parasite within the host tissue. Many factors influence infection, including temperature, seasonality, nutrient availability, and the presence or absence of microbes, as well as the developmental stage, sex, and genetics of the host. Several studies have identified host genomic regions that influence resistance to microsporidia, and future work is likely to uncover molecular mechanisms of microsporidia host specificity in more detail.

Comparative Genomics of Microsporidia
Williams B.A., Williams T.A., Trew J.
The microsporidia are a phylum of intracellular parasites that represent the eukaryotic cell in a state of extreme reduction, with genomes and metabolic capabilities embodying eukaryotic cells in arguably their most streamlined state. Over the past 20 years, microsporidian genomics has become a rapidly expanding field starting with sequencing of the genome of Encephalitozoon cuniculi, one of the first ever sequenced eukaryotes, to the current situation where we have access to the data from over 30 genomes across 20+ genera. Reaching back further in evolutionary history, to the point where microsporidia diverged from other eukaryotic lineages, we now also have genomic data for some of the closest known relatives of the microsporidia such as Rozella allomycis, Metchnikovella spp. and Amphiamblys sp. Data for these organisms allow us to better understand the genomic processes that shaped the emergence of the microsporidia as a group. These intensive genomic efforts have revealed some of the processes that have shaped microsporidian cells and genomes including patterns of genome expansions and contractions through gene gain and loss, whole genome duplication, differential patterns of invasion and purging of transposable elements. All these processes have been shown to occur across short and longer time scales to give rise to a phylum of parasites with dynamic genomes with a diversity of sizes and organisations.

Microsporidia
Experientia supplementum (2012)
,
2022
,
citations by CoLab: 10


Impact of Genome Reduction in Microsporidia
Jespersen N., Monrroy L., Barandun J.
AbstractMicrosporidia represent an evolutionary outlier in the tree of life and occupy the extreme edge of the eukaryotic domain with some of their biological features. Many of these unicellular fungi-like organisms have reduced their genomic content to potentially the lowest limit. With some of the most compacted eukaryotic genomes, microsporidia are excellent model organisms to study reductive evolution and its functional consequences. While the growing number of sequenced microsporidian genomes have elucidated genome composition and organization, a recent increase in complementary post-genomic studies has started to shed light on the impacts of genome reduction in these unique pathogens. This chapter will discuss the biological framework enabling genome minimization and will use one of the most ancient and essential macromolecular complexes, the ribosome, to illustrate the effects of extreme genome reduction on a structural, molecular, and cellular level. We outline how reductive evolution in microsporidia has shaped DNA organization, the composition and function of the ribosome, and the complexity of the ribosome biogenesis process. Studying compacted mechanisms, processes, or macromolecular machines in microsporidia illuminates their unique lifestyle and provides valuable insights for comparative eukaryotic structural biology.

Microsporidian Pathogens of Aquatic Animals
Bojko J., Stentiford G.D.
Around 57.1% of microsporidia occupy aquatic environments, excluding a further 25.7% that utilise both terrestrial and aquatic systems. The aquatic microsporidia therefore compose the most diverse elements of the Microsporidia phylum, boasting unique structural features, variable transmission pathways, and significant ecological influence. From deep oceans to tropical rivers, these parasites are present in most aquatic environments and have been shown to infect hosts from across the Protozoa and Animalia. The consequences of infection range from mortality to intricate behavioural change, and their presence in aquatic communities often alters the overall functioning of the ecosystem. In this chapter, we explore aquatic microsporidian diversity from the perspective of aquatic animal health. Examples of microsporidian parasitism of importance to an aquacultural (‘One Health’) context and ecosystem context are focussed upon. These include infection of commercially important penaeid shrimp by Enterocytozoon hepatopenaei and interesting hyperparasitic microsporidians of wild host groups. Out of ~1500 suggested microsporidian species, 202 have been adequately taxonomically described using a combination of ultrastructural and genetic techniques from aquatic and semi-aquatic hosts. These species are our primary focus, and we suggest that the remaining diversity have additional genetic or morphological data collected to formalise their underlying systematics.

Insights from C. elegans into Microsporidia Biology and Host-Pathogen Relationships
Tecle E., Troemel E.R.
Microsporidia are poorly understood, ubiquitous eukaryotic parasites that are completely dependent on their hosts for replication. With the discovery of microsporidia species naturally infecting the genetically tractable transparent nematode C. elegans, this host has been used to explore multiple areas of microsporidia biology. Here we review results about microsporidia infections in C. elegans, which began with the discovery of the intestinal-infecting species Nematocida parisii. Recent findings include new species identification in the Nematocida genus, with more intestinal-infecting species, and also a species with broader tissue tropism, the epidermal and muscle-infecting species Nematocida displodere. This species has a longer polar tube infection apparatus, which may enable its wider tissue range. After invasion, multiple Nematocida species appear to fuse host cells, which likely promotes their dissemination within host organs. Localized proteomics identified Nematocida proteins that have direct contact with the C. elegans intestinal cytosol and nucleus, and many of these host-exposed proteins belong to expanded, species-specific gene families. On the host side, forward genetic screens have identified regulators of the Intracellular Pathogen Response (IPR), which is a transcriptional response induced by both microsporidia and the Orsay virus, which is also a natural, obligate intracellular pathogen of the C. elegans intestine. The IPR constitutes a novel immune/stress response that promotes resistance against microsporidia, virus, and heat shock. Overall, the Nematocida/C. elegans system has provided insights about strategies for microsporidia pathogenesis, as well as innate defense pathways against these parasites.

The Function and Structure of the Microsporidia Polar Tube
Han B., Takvorian P.M., Weiss L.M.
Microsporidia are obligate intracellular pathogens that were initially identified about 160 years ago. Current phylogenetic analysis suggests that they are grouped with Cryptomycota as a basal branch or sister group to the fungi. Microsporidia are found worldwide and can infect a wide range of animals from invertebrates to vertebrates, including humans. They are responsible for a variety of diseases once thought to be restricted to immunocompromised patients but also occur in immunocompetent individuals. The small oval spore containing a coiled polar filament, which is part of the extrusion and invasion apparatus that transfers the infective sporoplasm to a new host, is a defining characteristic of all microsporidia. When the spore becomes activated, the polar filament uncoils and undergoes a rapid transition into a hollow tube that will transport the sporoplasm into a new cell. The polar tube has the ability to increase its diameter from approximately 100 nm to over 600 nm to accommodate the passage of an intact sporoplasm and penetrate the plasmalemma of the new host cell. During this process, various polar tube proteins appear to be involved in polar tube attachment to host cell and can interact with host proteins. These various interactions act to promote host cell infection.

Chronic Infections in Mammals Due to Microsporidia
Sak B., Kváč M.
Microsporidia are pathogenic organism related to fungi. They cause infections in a wide variety of mammals as well as in avian, amphibian, and reptilian hosts. Many microsporidia species play an important role in the development of serious diseases that have significant implications in human and veterinary medicine. While microsporidia were originally considered to be opportunistic pathogens in humans, it is now understood that infections also occur in immune competent humans. Encephalitozoon cuniculi, Encephalitozoon intestinalis, and Enterocytozoon bieneusi are primarily mammalian pathogens. However, many other species of microsporidia that have some other primary host that is not a mammal have been reported to cause sporadic mammalian infections. Experimental models and observations in natural infections have demonstrated that microsporidia can cause a latent infection in mammalian hosts. This chapter reviews the published studies on mammalian microsporidiosis and the data on chronic infections due to these enigmatic pathogens.

Immune Response to Microsporidia
Moretto M.M., Khan I.A.
Microsporidia are a group of pathogens, which can pose severe risks to the immunocompromised population, such as HIV-infected individuals or organ transplant recipients. Adaptive immunity has been reported to be critical for protection, and mice depleted of T cells are unable to control these infections. In a mouse model of infection, CD8 T cells have been found to be the primary effector cells and are responsible for protecting the infected host. Also, as infection is acquired via a peroral route, CD8 T cells in the gut compartment act as a first line of defense against these pathogens. Thus, generation of a robust CD8 T-cell response exhibiting polyfunctional ability is critical for host survival. In this chapter, we describe the effector CD8 T cells generated during microsporidia infection and the factors that may be essential for generating protective immunity against these understudied but significant pathogens. Overall, this chapter will highlight the necessity for a better understanding of the development of CD8 T-cell responses in gut-associated lymphoid tissue (GALT) and provide some insights into therapies that may be used to restore defective CD8 T-cell functionality in an immunocompromised situation.

Mechanics of Microsporidian Polar Tube Firing
Jaroenlak P., Usmani M., Ekiert D.C., Bhabha G.
As obligate intracellular parasites with reduced genomes, microsporidia must infect host cells in order to replicate and cause disease. They can initiate infection by utilizing a harpoon-like invasion organelle called the polar tube (PT). The PT is both visually and functionally a striking organelle and is a characteristic feature of the microsporidian phylum. Outside the host, microsporidia exist as transmissible, single-celled spores. Inside each spore, the PT is arranged as a tight coil. Upon germination, the PT undergoes a large conformational change into a long, linear tube and acts as a tunnel for the delivery of infectious cargo from the spore to a host cell. The firing process is extremely rapid, occurring on a millisecond timescale, and the emergent tube may be as long as 20 times the size of the spore body. In this chapter, we discuss what is known about the structure of the PT, the mechanics of the PT firing process, and how it enables movement of material from the spore body.

Recent Advances with Fish Microsporidia
Schuster C.J., Sanders J.L., Couch C., Kent M.L.
There have been several significant new findings regarding Microsporidia of fishes over the last decade. Here we provide an update on new taxa, new hosts and new diseases in captive and wild fishes since 2013. The importance of microsporidiosis continues to increase with the rapid growth of finfish aquaculture and the dramatic increase in the use of zebrafish as a model in biomedical research. In addition to reviewing new taxa and microsporidian diseases, we include discussions on advances with diagnostic methods, impacts of microsporidia on fish beyond morbidity and mortality, novel findings with transmission and invertebrate hosts, and a summary of the phylogenetics of fish microsporidia.

A Perspective on the Molecular Identification, Classification, and Epidemiology of Enterocytozoon bieneusi of Animals
Koehler A.V., Zhang Y., Gasser R.B.
The microsporidian Enterocytozoon bieneusi is an obligate intracellular pathogen that causes enteric disease (microsporidiosis) in humans and has been recorded in a wide range of animal species worldwide. The transmission of E. bieneusi is direct and likely occurs from person to person and from animal to person via the ingestion of spores in water, food, or the environment. The identification of E. bieneusi is usually accomplished by molecular means, typically using the sequence of the internal transcribed spacer (ITS) region of nuclear ribosomal DNA. Currently, ~820 distinct genotypes of E. bieneusi have been recorded in at least 210 species of vertebrates (mammals, birds, reptiles, and amphibians) or invertebrates (insects and mussels) in more than 50 countries. In this chapter, we provide a perspective on (1) clinical aspects of human microsporidiosis; (2) the genome and DNA markers for E. bieneusi as well as molecular methods for the specific and genotypic identification of E. bieneusi; (3) epidemiological aspects of E. bieneusi of animals and humans, with an emphasis on the genotypes proposed to be zoonotic, human-specific, and animal-specific; and (4) future research directions to underpin expanded molecular studies to better understand E. bieneusi and microsporidiosis.

Advances in the Genetic Manipulation of Nosema bombycis
Li T., Wei J., Pan G.
The microsporidium Nosema bombycis can infect and transmit both vertically and horizontally in multiple lepidopteran insects including silkworms and crop pests. While there have been several studies on the N. bombycis spore, there have been only limited studies on the N. bombycis sporoplasm. This chapter reviews what is known about this life cycle stage as well as published studies on purification of the N. bombycis sporoplasm and its survival in an in vitro cell culture system. Genetic transformation techniques have revolutionized the study of many pathogenic organisms. While progress has been made on the development of such systems for microsporidia, this critical problem has not been solved for these pathogens. This chapter provides a summary of the latest research progress on genetic manipulation of N. bombycis.

Nosema apis and N. ceranae Infection in Honey bees: A Model for Host-Pathogen Interactions in Insects
Snow J.W.
There has been increased focus on the role of microbial attack as a potential cause of recent declines in the health of the western honey bee, Apis mellifera. The Nosema species, N. apis and N. ceranae, are microsporidian parasites that are pathogenic to honey bees, and infection by these species has been implicated as a key factor in honey bee losses. Honey bees infected with both Nosema spp. display significant changes in their biology at the cellular, tissue, and organismal levels impacting host metabolism, immune function, physiology, and behavior. Infected individuals lead to colony dysfunction and can contribute to colony disease in some circumstances. The means through which parasite growth and tissue pathology in the midgut lead to the dramatic physiological and behavioral changes at the organismal level are only partially understood. In addition, we possess only a limited appreciation of the elements of the host environment that impact pathogen growth and development. Critical for answering these questions is a mechanistic understanding of the host and pathogen machinery responsible for host-pathogen interactions. A number of approaches are already being used to elucidate these mechanisms, and promising new tools may allow for gain- and loss-of-function experiments to accelerate future progress.
Top-100
Citing journals
2000
4000
6000
8000
10000
12000
|
|
Asian Pacific Journal of Cancer Prevention
11059 citations, 10.77%
|
|
PLoS ONE
1572 citations, 1.53%
|
|
International Journal of Molecular Sciences
1489 citations, 1.45%
|
|
Cancers
1382 citations, 1.35%
|
|
Oncology Letters
1291 citations, 1.26%
|
|
Scientific Reports
1209 citations, 1.18%
|
|
Oncotarget
1191 citations, 1.16%
|
|
Frontiers in Oncology
1166 citations, 1.14%
|
|
BMC Cancer
886 citations, 0.86%
|
|
Medicine (United States)
850 citations, 0.83%
|
|
Tumor Biology
833 citations, 0.81%
|
|
Biomedicine and Pharmacotherapy
609 citations, 0.59%
|
|
Molecules
568 citations, 0.55%
|
|
Molecular Medicine Reports
568 citations, 0.55%
|
|
Cureus
535 citations, 0.52%
|
|
International Journal of Environmental Research and Public Health
527 citations, 0.51%
|
|
Oncology Reports
507 citations, 0.49%
|
|
Nutrients
457 citations, 0.44%
|
|
Frontiers in Pharmacology
442 citations, 0.43%
|
|
BioMed Research International
419 citations, 0.41%
|
|
BMC Public Health
379 citations, 0.37%
|
|
BMC Women's Health
338 citations, 0.33%
|
|
Supportive Care in Cancer
317 citations, 0.31%
|
|
Molecular Biology Reports
312 citations, 0.3%
|
|
Journal of Cancer Education
300 citations, 0.29%
|
|
Cancer Medicine
300 citations, 0.29%
|
|
BMJ Open
299 citations, 0.29%
|
|
Heliyon
299 citations, 0.29%
|
|
Frontiers in Immunology
296 citations, 0.29%
|
|
Nutrition and Cancer
294 citations, 0.29%
|
|
Experimental and Therapeutic Medicine
280 citations, 0.27%
|
|
International Journal of Oncology
271 citations, 0.26%
|
|
Gene
261 citations, 0.25%
|
|
World Journal of Gastroenterology
259 citations, 0.25%
|
|
Journal of Clinical Medicine
258 citations, 0.25%
|
|
Medical Oncology
250 citations, 0.24%
|
|
Pathology Research and Practice
245 citations, 0.24%
|
|
Biomedicines
228 citations, 0.22%
|
|
Cells
228 citations, 0.22%
|
|
Cancer Cell International
225 citations, 0.22%
|
|
Journal of Cellular Physiology
222 citations, 0.22%
|
|
Journal of Cellular Biochemistry
219 citations, 0.21%
|
|
World Journal of Surgical Oncology
215 citations, 0.21%
|
|
Frontiers in Public Health
215 citations, 0.21%
|
|
Antioxidants
213 citations, 0.21%
|
|
Life Sciences
210 citations, 0.2%
|
|
International Journal of Cancer
210 citations, 0.2%
|
|
Cancer Letters
201 citations, 0.2%
|
|
Bioscience Reports
199 citations, 0.19%
|
|
Diagnostics
199 citations, 0.19%
|
|
Frontiers in Genetics
193 citations, 0.19%
|
|
Journal of Ethnopharmacology
192 citations, 0.19%
|
|
Cancer Epidemiology
187 citations, 0.18%
|
|
Translational Cancer Research
187 citations, 0.18%
|
|
Evidence-based Complementary and Alternative Medicine
185 citations, 0.18%
|
|
Journal of Cancer Research and Clinical Oncology
184 citations, 0.18%
|
|
Cancer Management and Research
181 citations, 0.18%
|
|
Breast Cancer Research and Treatment
175 citations, 0.17%
|
|
Biomolecules
167 citations, 0.16%
|
|
Molecular and Clinical Oncology
164 citations, 0.16%
|
|
Biochemical and Biophysical Research Communications
164 citations, 0.16%
|
|
Oxidative Medicine and Cellular Longevity
163 citations, 0.16%
|
|
Healthcare
162 citations, 0.16%
|
|
Cancer Biomarkers
158 citations, 0.15%
|
|
Artificial Cells, Nanomedicine and Biotechnology
155 citations, 0.15%
|
|
Seminars in Cancer Biology
155 citations, 0.15%
|
|
European Journal of Cancer Care
155 citations, 0.15%
|
|
Journal of Gastrointestinal Cancer
153 citations, 0.15%
|
|
Journal of Cancer Research and Therapeutics
148 citations, 0.14%
|
|
F1000Research
148 citations, 0.14%
|
|
Phytotherapy Research
145 citations, 0.14%
|
|
Environmental Science and Pollution Research
141 citations, 0.14%
|
|
PeerJ
139 citations, 0.14%
|
|
Critical Reviews in Oncology/Hematology
139 citations, 0.14%
|
|
Cell Death and Disease
139 citations, 0.14%
|
|
Future Oncology
136 citations, 0.13%
|
|
Anti-Cancer Agents in Medicinal Chemistry
134 citations, 0.13%
|
|
Journal of Translational Medicine
134 citations, 0.13%
|
|
Pharmaceuticals
133 citations, 0.13%
|
|
Pharmaceutics
133 citations, 0.13%
|
|
Gene Reports
133 citations, 0.13%
|
|
Cancer Control
133 citations, 0.13%
|
|
International Journal of Biological Macromolecules
133 citations, 0.13%
|
|
Pharmacological Research
132 citations, 0.13%
|
|
Genes
132 citations, 0.13%
|
|
Disease Markers
129 citations, 0.13%
|
|
Advances in Experimental Medicine and Biology
129 citations, 0.13%
|
|
International Journal of Molecular Medicine
127 citations, 0.12%
|
|
Indian Journal of Surgical Oncology
125 citations, 0.12%
|
|
European Journal of Oncology Nursing
124 citations, 0.12%
|
|
Indian Journal of Gynecologic Oncology
124 citations, 0.12%
|
|
Frontiers in Cell and Developmental Biology
123 citations, 0.12%
|
|
Journal of Drug Delivery Science and Technology
122 citations, 0.12%
|
|
European Journal of Pharmacology
121 citations, 0.12%
|
|
International Journal of Cancer Management
120 citations, 0.12%
|
|
International Immunopharmacology
119 citations, 0.12%
|
|
Journal of International Medical Research
119 citations, 0.12%
|
|
Clinical Breast Cancer
117 citations, 0.11%
|
|
Aging
115 citations, 0.11%
|
|
Journal of Experimental and Clinical Cancer Research
115 citations, 0.11%
|
|
Show all (70 more) | |
2000
4000
6000
8000
10000
12000
|
Citing publishers
2000
4000
6000
8000
10000
12000
14000
16000
18000
|
|
Springer Nature
17281 citations, 16.82%
|
|
Elsevier
15909 citations, 15.49%
|
|
Asian Pacific Organization for Cancer Prevention
11079 citations, 10.79%
|
|
MDPI
8312 citations, 8.09%
|
|
Wiley
6975 citations, 6.79%
|
|
Taylor & Francis
4348 citations, 4.23%
|
|
Frontiers Media S.A.
3512 citations, 3.42%
|
|
Spandidos Publications
3393 citations, 3.3%
|
|
Ovid Technologies (Wolters Kluwer Health)
2996 citations, 2.92%
|
|
SAGE
2655 citations, 2.58%
|
|
Hindawi Limited
1908 citations, 1.86%
|
|
Public Library of Science (PLoS)
1695 citations, 1.65%
|
|
Impact Journals
1322 citations, 1.29%
|
|
Bentham Science Publishers Ltd.
1033 citations, 1.01%
|
|
Oxford University Press
830 citations, 0.81%
|
|
AME Publishing Company
727 citations, 0.71%
|
|
BMJ
627 citations, 0.61%
|
|
Baishideng Publishing Group
601 citations, 0.59%
|
|
Mary Ann Liebert
509 citations, 0.5%
|
|
Royal Society of Chemistry (RSC)
433 citations, 0.42%
|
|
American Chemical Society (ACS)
425 citations, 0.41%
|
|
Medknow
390 citations, 0.38%
|
|
380 citations, 0.37%
|
|
Georg Thieme Verlag KG
377 citations, 0.37%
|
|
Cold Spring Harbor Laboratory
326 citations, 0.32%
|
|
American Association for Cancer Research (AACR)
309 citations, 0.3%
|
|
Institute of Electrical and Electronics Engineers (IEEE)
306 citations, 0.3%
|
|
IOS Press
305 citations, 0.3%
|
|
American Society of Clinical Oncology (ASCO)
279 citations, 0.27%
|
|
Walter de Gruyter
276 citations, 0.27%
|
|
272 citations, 0.26%
|
|
S. Karger AG
258 citations, 0.25%
|
|
Cambridge University Press
218 citations, 0.21%
|
|
King Saud University
174 citations, 0.17%
|
|
Research Square Platform LLC
166 citations, 0.16%
|
|
IOP Publishing
165 citations, 0.16%
|
|
JMIR Publications
165 citations, 0.16%
|
|
SciELO
162 citations, 0.16%
|
|
IntechOpen
155 citations, 0.15%
|
|
F1000 Research
152 citations, 0.15%
|
|
PeerJ
150 citations, 0.15%
|
|
Brieflands
138 citations, 0.13%
|
|
132 citations, 0.13%
|
|
Jaypee Brothers Medical Publishing
125 citations, 0.12%
|
|
Moffitt Cancer Center
122 citations, 0.12%
|
|
Pleiades Publishing
118 citations, 0.11%
|
|
AIP Publishing
111 citations, 0.11%
|
|
Scientific Research Publishing
105 citations, 0.1%
|
|
Maad Rayan Publishing Company
99 citations, 0.1%
|
|
Hans Publishers
99 citations, 0.1%
|
|
IGI Global
91 citations, 0.09%
|
|
American Medical Association (AMA)
90 citations, 0.09%
|
|
Neoplasia Press
90 citations, 0.09%
|
|
OAE Publishing Inc.
84 citations, 0.08%
|
|
Emerald
80 citations, 0.08%
|
|
67 citations, 0.07%
|
|
Society for Translational Oncology
67 citations, 0.07%
|
|
60 citations, 0.06%
|
|
Scientific Scholar
60 citations, 0.06%
|
|
EDP Sciences
57 citations, 0.06%
|
|
XMLink
57 citations, 0.06%
|
|
Korean Cancer Association
56 citations, 0.05%
|
|
Publishing House ABV Press
55 citations, 0.05%
|
|
World Scientific
54 citations, 0.05%
|
|
Korean Society of Cancer Prevention
53 citations, 0.05%
|
|
PAGEPress Publications
53 citations, 0.05%
|
|
A and V Publications
51 citations, 0.05%
|
|
American Scientific Publishers
50 citations, 0.05%
|
|
Science Alert
50 citations, 0.05%
|
|
American Physiological Society
49 citations, 0.05%
|
|
Korean Society of Epidemiology
49 citations, 0.05%
|
|
Mark Allen Group
49 citations, 0.05%
|
|
Media Sphere Publishing House
49 citations, 0.05%
|
|
Pharmaceutical Society of Japan
47 citations, 0.05%
|
|
Portland Press
45 citations, 0.04%
|
|
Oriental Scientific Publishing Company
44 citations, 0.04%
|
|
Begell House
43 citations, 0.04%
|
|
American Institute of Mathematical Sciences (AIMS)
39 citations, 0.04%
|
|
Eco-Vector LLC
39 citations, 0.04%
|
|
American Society for Nutrition
39 citations, 0.04%
|
|
Korean Society for Preventive Medicine
38 citations, 0.04%
|
|
Federation of American Societies for Experimental Biology (FASEB)
38 citations, 0.04%
|
|
American Society for Biochemistry and Molecular Biology
37 citations, 0.04%
|
|
DoNotEdit
37 citations, 0.04%
|
|
Canadian Science Publishing
36 citations, 0.04%
|
|
Ubiquity Press
36 citations, 0.04%
|
|
The Endocrine Society
35 citations, 0.03%
|
|
American Society for Microbiology
34 citations, 0.03%
|
|
Edizioni Minerva Medica
34 citations, 0.03%
|
|
Korean Academy of Medical Sciences
33 citations, 0.03%
|
|
Bioscientifica
33 citations, 0.03%
|
|
Tech Science Press
32 citations, 0.03%
|
|
International Dose-Response Society
31 citations, 0.03%
|
|
31 citations, 0.03%
|
|
Radiological Society of North America (RSNA)
30 citations, 0.03%
|
|
Associacao Brasileira de Enfermagem
29 citations, 0.03%
|
|
British Institute of Radiology
29 citations, 0.03%
|
|
Pharmaceutical Society of Korea
28 citations, 0.03%
|
|
Japan Epidemiological Association
28 citations, 0.03%
|
|
Oncology Nursing Society
27 citations, 0.03%
|
|
Show all (70 more) | |
2000
4000
6000
8000
10000
12000
14000
16000
18000
|
5 profile journal articles
Roshanaei Ghodratollah
🥼
PhD in Biological/biomedical sciences, Professor

Hamedan University of Medical Sciences
156 publications,
849 citations
h-index: 16
3 profile journal articles
Irshad Mohammad
54 publications,
1 092 citations
h-index: 19
1 profile journal article
Perveen Shagufta

King Saud University

University of the Punjab

Government College University, Faisalabad
160 publications,
2 051 citations
h-index: 22
1 profile journal article
De Velasco Marco

Kindai University
99 publications,
2 839 citations
h-index: 31
1 profile journal article
Emran Talha

Brown University

BGC Trust University Bangladesh
547 publications,
14 253 citations
h-index: 59
1 profile journal article
Kundu Sharbadeb
23 publications,
134 citations
h-index: 7
1 profile journal article
Cetinkaya Kadir
29 publications,
138 citations
h-index: 7
1 profile journal article
KARABAY OĞUZ

Sakarya University
227 publications,
2 732 citations
h-index: 26
1 profile journal article
Mortazavi Mojtaba
49 publications,
488 citations
h-index: 12
1 profile journal article
Khatibi Toktam
41 publications,
435 citations
h-index: 12
1 profile journal article
Yadav Amit
🥼 🤝
PhD in Law

University of Allahabad

Rajiv Gandhi University

University of California, San Francisco

Public Health Foundation of India
47 publications,
309 citations
h-index: 10
1 profile journal article
Shahat Abdelaaty
163 publications,
2 606 citations
h-index: 28